{
  "$schema": "folio-library-document/v1",
  "id": "10665-259268",
  "title": "WHO recommendations on maternal health: guidelines approved by the WHO Guidelines Review Committee",
  "variant": "pdf",
  "pages": 36,
  "tocSource": "inferred",
  "tocMethod": "contents",
  "toc": [
    {
      "level": 1,
      "title": "Abbreviations",
      "number": null,
      "page": 6,
      "pageLabel": "iv",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-000-abbreviations"
    },
    {
      "level": 1,
      "title": "Introduction",
      "number": null,
      "page": 7,
      "pageLabel": "1",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-001-introduction"
    },
    {
      "level": 1,
      "title": "Promote, prevent and protect maternal and perinatal health",
      "number": null,
      "page": 9,
      "pageLabel": "3",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-002-promote-prevent-and-protect-maternal-and-perinat"
    },
    {
      "level": 1,
      "title": "Antenatal care",
      "number": "1",
      "page": 9,
      "pageLabel": "3",
      "confidence": 0.8,
      "evidence": [
        "contents",
        "body",
        "number"
      ],
      "source": "inferred",
      "section": "sec-003-1-antenatal-care"
    },
    {
      "level": 2,
      "title": "Nutritional supplements",
      "number": null,
      "page": 9,
      "pageLabel": "3",
      "confidence": 0.5,
      "evidence": [
        "contents"
      ],
      "source": "inferred",
      "section": "sec-004-nutritional-supplements"
    },
    {
      "level": 2,
      "title": "Maternal and fetal assessment",
      "number": null,
      "page": 10,
      "pageLabel": "4",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-005-maternal-and-fetal-assessment"
    },
    {
      "level": 2,
      "title": "Preventive measures",
      "number": null,
      "page": 12,
      "pageLabel": "6",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-006-preventive-measures"
    },
    {
      "level": 2,
      "title": "Interventions for common physiological symptoms",
      "number": null,
      "page": 13,
      "pageLabel": "7",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-007-interventions-for-common-physiological-symptoms"
    },
    {
      "level": 2,
      "title": "Health systems interventions",
      "number": null,
      "page": 14,
      "pageLabel": "8",
      "confidence": 0.75,
      "evidence": [
        "contents",
        "body"
      ],
      "source": "inferred",
      "section": "sec-008-health-systems-interventions"
    },
    {
      "level": 1,
      "title": "Prevention of pre-eclampsia and eclampsia",
      "number": "2",
      "page": 15,
      "pageLabel": "9",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-009-2-prevention-of-pre-eclampsia-and-eclampsia"
    },
    {
      "level": 1,
      "title": "Interventions to improve preterm birth outcomes",
      "number": "3",
      "page": 16,
      "pageLabel": "10",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-010-3-interventions-to-improve-preterm-birth-outcome"
    },
    {
      "level": 1,
      "title": "Prevention of maternal peripartum infections",
      "number": "4",
      "page": 18,
      "pageLabel": "12",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-011-4-prevention-of-maternal-peripartum-infections"
    },
    {
      "level": 1,
      "title": "Labour and child birth",
      "number": "5",
      "page": 19,
      "pageLabel": "13",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-012-5-labour-and-child-birth"
    },
    {
      "level": 2,
      "title": "Induction of labour",
      "number": null,
      "page": 19,
      "pageLabel": "13",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-013-induction-of-labour"
    },
    {
      "level": 2,
      "title": "Delay in the first stage of labour",
      "number": null,
      "page": 20,
      "pageLabel": "14",
      "confidence": 0.5,
      "evidence": [
        "contents"
      ],
      "source": "inferred",
      "section": "sec-014-delay-in-the-first-stage-of-labour"
    },
    {
      "level": 2,
      "title": "Augmentation of labour",
      "number": null,
      "page": 21,
      "pageLabel": "15",
      "confidence": 0.5,
      "evidence": [
        "contents"
      ],
      "source": "inferred",
      "section": null
    },
    {
      "level": 1,
      "title": "Prevention of postpartum haemorrhage",
      "number": "6",
      "page": 21,
      "pageLabel": "15",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-015-6-prevention-of-postpartum-haemorrhage"
    },
    {
      "level": 1,
      "title": "Postnatal care",
      "number": "7",
      "page": 22,
      "pageLabel": "16",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-016-7-postnatal-care"
    },
    {
      "level": 1,
      "title": ". Health promotion for maternal and newborn health",
      "number": "8",
      "page": 25,
      "pageLabel": "19",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-017-8-health-promotion-for-maternal-and-newborn-heal"
    },
    {
      "level": 1,
      "title": "Management of maternal conditions",
      "number": null,
      "page": 28,
      "pageLabel": "22",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-018-management-of-maternal-conditions"
    },
    {
      "level": 1,
      "title": "Postpartum haemorrhage",
      "number": "9",
      "page": 28,
      "pageLabel": "22",
      "confidence": 0.55,
      "evidence": [
        "contents",
        "number"
      ],
      "source": "inferred",
      "section": "sec-019-9-postpartum-haemorrhage"
    },
    {
      "level": 1,
      "title": "Pre-eclampsia and eclampsia",
      "number": "10",
      "page": 29,
      "pageLabel": "23",
      "confidence": 0.55,
      "evidence": [
        "contents",
        "number"
      ],
      "source": "inferred",
      "section": "sec-020-10-pre-eclampsia-and-eclampsia"
    },
    {
      "level": 1,
      "title": "Peripartum infections",
      "number": "11",
      "page": 30,
      "pageLabel": "24",
      "confidence": 0.55,
      "evidence": [
        "contents",
        "number"
      ],
      "source": "inferred",
      "section": "sec-021-11-peripartum-infections"
    },
    {
      "level": 1,
      "title": "HIV infection",
      "number": "12",
      "page": 30,
      "pageLabel": "24",
      "confidence": 0.8,
      "evidence": [
        "contents",
        "body",
        "number"
      ],
      "source": "inferred",
      "section": "sec-022-12-hiv-infection"
    },
    {
      "level": 1,
      "title": "Malaria",
      "number": "13",
      "page": 33,
      "pageLabel": "27",
      "confidence": 0.55,
      "evidence": [
        "contents",
        "number"
      ],
      "source": "inferred",
      "section": "sec-023-13-malaria"
    },
    {
      "level": 1,
      "title": "Tuberculosis",
      "number": "14",
      "page": 33,
      "pageLabel": "27",
      "confidence": 0.8,
      "evidence": [
        "contents",
        "body",
        "number"
      ],
      "source": "inferred",
      "section": "sec-024-14-tuberculosis"
    }
  ],
  "sections": [
    {
      "id": "sec-front-matter",
      "number": null,
      "title": "Front matter",
      "level": 1,
      "pageStart": 1,
      "pageEnd": 6,
      "labelStart": "A",
      "labelEnd": "iv",
      "words": 645,
      "summary": {
        "text": "The front matter of WHO recommendations on maternal health (updated May 2017, WHO/MCA/17.10): title page, copyright and licence page with suggested citation and disclaimers, and a table of contents listing antenatal, childbirth, postnatal and maternal-condition chapters.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "postpartum haemorrhage",
          "heading": false
        },
        {
          "term": "maternal health",
          "heading": false
        },
        {
          "term": "peripartum infections",
          "heading": false
        },
        {
          "term": "creative commons",
          "heading": false
        },
        {
          "term": "guidelines approved",
          "heading": false
        },
        {
          "term": "health organization",
          "heading": false
        },
        {
          "term": "suggested citation",
          "heading": false
        },
        {
          "term": "world health",
          "heading": false
        }
      ],
      "extract": "WHO RECOMMENDATIONS ON Maternal Health GUIDELINES APPROVED BY THE WHO GUIDELINES REVIEW COMMITTEE UPDATED MAY 2017 WHO RECOMMENDATIONS ON Maternal Health GUIDELINES APPROVED BY THE WHO GUIDELINES REVIEW COMMITTEE UPDATED MAY 2017 WHO/MCA/17.10 © World Health Organization 2017 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial- ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0",
      "extractCut": true,
      "blocks": [
        "library/10665-259268/blocks/prose-sec-front-matter"
      ]
    },
    {
      "id": "sec-000-abbreviations",
      "number": null,
      "title": "Abbreviations",
      "level": 1,
      "pageStart": 6,
      "pageEnd": 7,
      "labelStart": "iv",
      "labelEnd": "1",
      "words": 74,
      "summary": {
        "text": "A list of abbreviations used in the maternal health recommendations, mostly HIV drugs and terms, along with care and guideline-process acronyms.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "transcriptase inhibitor",
          "heading": false
        },
        {
          "term": "reverse transcriptase",
          "heading": false
        },
        {
          "term": "cct",
          "heading": false
        },
        {
          "term": "efz",
          "heading": false
        }
      ],
      "extract": "AIDS acquired immunodeficiency syndrome ANC antenatal care ART antiretroviral therapy ARV antiretroviral AZT zidovudine CCT controlled cord traction EFZ efavirenz FTC emtricitabine GRADE Grading of Recommendations, Assessment, Development and Evaluation GRC Guidelines Review Committee GDG Guidelines Development Group HIV human immunodeficiency virus IM intramuscular IV intravenous 3TC lamuvidine NVP nevirapine NNRTI",
      "extractCut": true
    },
    {
      "id": "sec-001-introduction",
      "number": null,
      "title": "Introduction",
      "level": 1,
      "pageStart": 7,
      "pageEnd": 9,
      "labelStart": "1",
      "labelEnd": "3",
      "words": 519,
      "summary": {
        "text": "Introduces a compilation of WHO maternal health recommendations, one of a four-part series, aimed at WHO personnel, policy-makers, programme managers and health practitioners and to help identify gaps for updating guidelines. Explains how WHO develops guidelines using GRADE ratings of evidence quality and a structured evidence-to-decision framework leading to strong or conditional recommendations, and notes that items are flagged as New or Update relative to 2013.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "expert group",
          "heading": false
        },
        {
          "term": "guideline development",
          "heading": false
        },
        {
          "term": "recommendation",
          "heading": false
        },
        {
          "term": "maternal health",
          "heading": false
        },
        {
          "term": "further research",
          "heading": false
        },
        {
          "term": "practise",
          "heading": false
        },
        {
          "term": "conditional",
          "heading": false
        },
        {
          "term": "effect",
          "heading": false
        }
      ],
      "extract": "Introduction This publication on WHO recommendations related to maternal health is one of four in a series; the others relate to newborn, child and adolescent health. The objective of this document is to make available WHO recommendations on maternal health in one easy-to-access document for WHO staff, policy-makers, programme managers, and health professionals. The compilation can also help better define gaps to",
      "extractCut": true
    },
    {
      "id": "sec-002-promote-prevent-and-protect-maternal-and-perinat",
      "number": null,
      "title": "Promote, prevent and protect maternal and perinatal health",
      "level": 1,
      "pageStart": 9,
      "pageEnd": 9,
      "labelStart": "3",
      "labelEnd": "3",
      "words": 5,
      "summary": {
        "text": "A section heading for promoting, preventing and protecting maternal and perinatal health, marked as new.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "maternal and perinatal health NEW",
      "extractCut": false
    },
    {
      "id": "sec-003-1-antenatal-care",
      "number": "1",
      "title": "Antenatal care",
      "level": 1,
      "pageStart": 9,
      "pageEnd": 9,
      "labelStart": "3",
      "labelEnd": "3",
      "words": 7,
      "summary": {
        "text": "A heading introducing antenatal care for a positive pregnancy experience.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "ANTENATAL CARE FOR A POSITIVE PREGNANCY EXPERIENCE",
      "extractCut": false
    },
    {
      "id": "sec-004-nutritional-supplements",
      "number": null,
      "title": "Nutritional supplements",
      "level": 2,
      "pageStart": 9,
      "pageEnd": 10,
      "labelStart": "3",
      "labelEnd": "4",
      "words": 441,
      "summary": {
        "text": "Lists WHO antenatal recommendations on diet and supplements, including counselling on healthy eating and activity, energy and protein measures in undernourished populations, daily or weekly iron and folic acid, and calcium where intake is low. Vitamin A and zinc are advised only in specific contexts, multiple micronutrients and vitamins B6, C, D and E are not recommended, and lowering caffeine intake is advised for heavy consumers.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "vitamin supplementation",
          "heading": false
        },
        {
          "term": "supplements",
          "heading": true
        },
        {
          "term": "elemental iron",
          "heading": false
        },
        {
          "term": "acid supplementation",
          "heading": false
        },
        {
          "term": "caffeine intake",
          "heading": false
        },
        {
          "term": "pregnant women",
          "heading": false
        },
        {
          "term": "context-specific recommendation",
          "heading": false
        },
        {
          "term": "folic acid",
          "heading": false
        }
      ],
      "extract": "■ ■Counselling about healthy eating and keeping physically active during pregnancy is recommended for pregnant women to stay healthy and to prevent excessive weight gain during pregnancy. (Recommended). Source ■ ■In undernourished populations, nutrition education on increasing daily energy and protein intake is recommended for pregnant women to reduce the risk of low-birth-weight neonates. (Context-specific",
      "extractCut": true
    },
    {
      "id": "sec-005-maternal-and-fetal-assessment",
      "number": null,
      "title": "Maternal and fetal assessment",
      "level": 2,
      "pageStart": 10,
      "pageEnd": 12,
      "labelStart": "4",
      "labelEnd": "6",
      "words": 587,
      "summary": {
        "text": "Sets out recommended antenatal assessments, including preferred tests for anaemia and asymptomatic bacteriuria, classifying hyperglycaemia found in pregnancy, HIV testing and counselling, TB screening in high-prevalence settings, and asking about intimate partner violence, tobacco and other substance use. It also states that routine cardiotocography, Doppler scans and replacing palpation with fundal-height measurement are not recommended, kick-chart counting only in research, and one ultrasound before 24 weeks is advised.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "fetal",
          "heading": true
        },
        {
          "term": "doppler ultrasound",
          "heading": false
        },
        {
          "term": "ultrasound scan",
          "heading": false
        },
        {
          "term": "context-specific recommendation",
          "heading": false
        },
        {
          "term": "fetal movement",
          "heading": false
        },
        {
          "term": "antenatal cardiotocography",
          "heading": false
        },
        {
          "term": "recommended method",
          "heading": false
        },
        {
          "term": "pregnant women",
          "heading": false
        }
      ],
      "extract": "Anaemia ■ ■Full blood count testing is the recommended method for diagnosing anaemia in pregnancy. In settings where full blood count testing is not available, on-site haemoglobin testing with a haemoglobinometer is recommended over the use of the haemoglobin colour scale as the method for diagnosing anaemia in pregnancy. (Context-specific recommendation). Source Asymptomatic bacteriuria (ASB) ■ ■Midstream urine",
      "extractCut": true
    },
    {
      "id": "sec-006-preventive-measures",
      "number": null,
      "title": "Preventive measures",
      "level": 2,
      "pageStart": 12,
      "pageEnd": 13,
      "labelStart": "6",
      "labelEnd": "7",
      "words": 509,
      "summary": {
        "text": "Lists preventive measures in pregnancy, such as a seven-day antibiotic course for asymptomatic bacteriuria, deworming in endemic areas after the first trimester, tetanus toxoid and influenza vaccination, bed nets and sulfadoxine-pyrimethamine preventive treatment against malaria. Anti-D prophylaxis and antibiotics for recurrent urinary infections are reserved for research, and the section also covers primaquine use to prevent vivax or ovale malaria relapse according to G6PD status and oral PrEP for pregnant women at substantial HIV risk.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "context-specific recommendation",
          "heading": false
        },
        {
          "term": "pregnant women",
          "heading": false
        },
        {
          "term": "prevent relapse",
          "heading": false
        },
        {
          "term": "antibiotic prophylaxis",
          "heading": false
        },
        {
          "term": "ovale malaria",
          "heading": false
        },
        {
          "term": "anti-d immunoglobulin",
          "heading": false
        },
        {
          "term": "preventive anthelminthic",
          "heading": false
        },
        {
          "term": "strong recommendation",
          "heading": false
        }
      ],
      "extract": "Antibiotics for asymptomatic bacteriuria (ASB) ■ ■A seven-day antibiotic regimen is recommended for all pregnant women with asymptomatic bacteriuria (ASB) to prevent persistent bacteriuria, preterm birth and low birth weight. (Recommended). Source Antibiotic prophylaxis to prevent recurrent urinary tract infections (RUTI) ■ ■Antibiotic prophylaxis is only recommended to prevent recurrent urinary tract infections in",
      "extractCut": true
    },
    {
      "id": "sec-007-interventions-for-common-physiological-symptoms",
      "number": null,
      "title": "Interventions for common physiological symptoms",
      "level": 2,
      "pageStart": 13,
      "pageEnd": 14,
      "labelStart": "7",
      "labelEnd": "8",
      "words": 223,
      "summary": {
        "text": "Gives recommended options for common pregnancy discomforts, including ginger, chamomile, vitamin B6 or acupuncture for nausea and diet and lifestyle advice or antacids for heartburn. It also covers leg cramps, low back and pelvic pain, constipation, and varicose veins and oedema, with choices guided by the woman's preferences and what is available.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "woman preferences",
          "heading": false
        },
        {
          "term": "leg cramps",
          "heading": false
        },
        {
          "term": "varicose veins",
          "heading": false
        },
        {
          "term": "available options",
          "heading": false
        },
        {
          "term": "pelvic pain",
          "heading": false
        },
        {
          "term": "treatment options",
          "heading": false
        },
        {
          "term": "non-pharmacological",
          "heading": false
        }
      ],
      "extract": "Nausea and vomiting ■ ■Ginger, chamomile, vitamin B6 and/or acupuncture are recommended for the relief of nausea in early pregnancy, based on a woman’s preferences and available options. (Recommended). Source Heartburn ■ ■Advice on diet and lifestyle is recommended to prevent and relieve heartburn in pregnancy. Antacid preparations can be offered to women with troublesome symptoms that are not relieved by lifestyle",
      "extractCut": true
    },
    {
      "id": "sec-008-health-systems-interventions",
      "number": null,
      "title": "Health systems interventions",
      "level": 2,
      "pageStart": 14,
      "pageEnd": 15,
      "labelStart": "8",
      "labelEnd": "9",
      "words": 401,
      "summary": {
        "text": "Lists health-system recommendations for antenatal care, including women carrying their own case notes, midwife-led continuity of care, group antenatal care in research settings, women's group participatory learning cycles, and community mobilization with home visits. It also covers task shifting of health promotion and supplement distribution to various cadres, measures to recruit and keep health workers in rural areas, and a schedule of at least eight antenatal contacts.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "antenatal care",
          "heading": false
        },
        {
          "term": "auxiliary nurses",
          "heading": false
        },
        {
          "term": "context-specific recommendation",
          "heading": false
        },
        {
          "term": "antenatal home",
          "heading": false
        },
        {
          "term": "group antenatal",
          "heading": false
        },
        {
          "term": "pregnant women",
          "heading": false
        },
        {
          "term": "facilitated participatory",
          "heading": false
        },
        {
          "term": "task shifting",
          "heading": false
        }
      ],
      "extract": "antenatal care Woman-held case notes ■ ■It is recommended that each pregnant woman carries her own case notes during pregnancy to improve continuity, quality of care and her pregnancy experience. (Recommended). Source Midwife-led continuity of care ■ ■Midwife-led continuity-of-care models, in which a known midwife or small group of known midwives supports a woman throughout the antenatal, intrapartum and postnatal",
      "extractCut": true
    },
    {
      "id": "sec-009-2-prevention-of-pre-eclampsia-and-eclampsia",
      "number": "2",
      "title": "Prevention of pre-eclampsia and eclampsia",
      "level": 1,
      "pageStart": 15,
      "pageEnd": 16,
      "labelStart": "9",
      "labelEnd": "10",
      "words": 241,
      "summary": {
        "text": "Sets out recommendations on preventing pre-eclampsia and eclampsia, including calcium supplements where intake is low, low-dose aspirin for high-risk women started before 20 weeks, and treating severe hypertension. Home rest, strict bed rest, salt restriction and diuretics such as thiazides are not recommended for this purpose.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "pre-eclampsia",
          "heading": true
        },
        {
          "term": "weak recommendation",
          "heading": false
        },
        {
          "term": "eclampsia",
          "heading": true
        },
        {
          "term": "source low-dose",
          "heading": false
        },
        {
          "term": "strong recommendation",
          "heading": false
        },
        {
          "term": "pre eclampsia",
          "heading": false
        },
        {
          "term": "quality evidence",
          "heading": false
        },
        {
          "term": "during pregnancy",
          "heading": false
        }
      ],
      "extract": "PREVENTION OF PRE-ECLAMPSIA AND ECLAMPSIA ■ ■In populations with low dietary calcium intake, daily calcium supplementation (1.5–2.0 g oral elemental calcium) is recommended for pregnant women to reduce the risk of pre- eclampsia. (Context-specific recommendation). Source ■ ■Low-dose acetylsalicylic acid (aspirin, 75 mg) is recommended for the prevention of pre- eclampsia in women at high risk of developing the",
      "extractCut": true
    },
    {
      "id": "sec-010-3-interventions-to-improve-preterm-birth-outcome",
      "number": "3",
      "title": "Interventions to improve preterm birth outcomes",
      "level": 1,
      "pageStart": 16,
      "pageEnd": 18,
      "labelStart": "10",
      "labelEnd": "12",
      "words": 723,
      "summary": {
        "text": "Presents new recommendations to improve outcomes of preterm birth, centred on antenatal corticosteroids for women at risk between 24 and 34 weeks when conditions such as accurate dating, imminent birth, no maternal infection and adequate maternal and newborn care are met. It specifies use in multiple pregnancies, preterm prelabour rupture of membranes, hypertensive disorders, fetal growth restriction and diabetes, names dexamethasone or betamethasone as the drugs of choice, allows one repeat course, and excludes chorioamnionitis and planned late-preterm caesarean section. It also advises against tocolytics, routine antibiotics with intact membranes and routine caesarean delivery, while recommending magnesium sulfate before 32 weeks and antibiotics such as erythromycin after membrane rupture, but not co-amoxiclav.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "preterm birth",
          "heading": true
        },
        {
          "term": "imminent preterm",
          "heading": false
        },
        {
          "term": "antenatal corticosteroid",
          "heading": false
        },
        {
          "term": "preterm prelabour",
          "heading": false
        },
        {
          "term": "corticosteroid therapy",
          "heading": false
        },
        {
          "term": "preterm newborn",
          "heading": false
        },
        {
          "term": "low-quality evidence",
          "heading": false
        },
        {
          "term": "moderate-quality evidence",
          "heading": false
        }
      ],
      "extract": "INTERVENTIONS TO IMPROVE PRETERM BIRTH OUTCOMES NEW Antenatal corticosteroids to improve newborn outcomes ■ ■Antenatal corticosteroid therapy is recommended for women at risk of preterm birth from 24 weeks to 34 weeks of gestation when the following conditions are met: — — gestational age assessment can be accurately undertaken; — — preterm birth is considered imminent; — — there is no clinical evidence of maternal",
      "extractCut": true
    },
    {
      "id": "sec-011-4-prevention-of-maternal-peripartum-infections",
      "number": "4",
      "title": "Prevention of maternal peripartum infections",
      "level": 1,
      "pageStart": 18,
      "pageEnd": 19,
      "labelStart": "12",
      "labelEnd": "13",
      "words": 529,
      "summary": {
        "text": "Lists new recommendations on preventing maternal infections around childbirth, advising against routine shaving, chlorhexidine vaginal cleansing and routine antibiotics in situations such as preterm labour with intact membranes, term membrane rupture, meconium, operative vaginal birth, episiotomy and uncomplicated birth. Antibiotics are recommended for GBS colonization, preterm membrane rupture, manual placenta removal, severe perineal tears and caesarean section, given before incision as a single dose of first-generation cephalosporin or penicillin, with povidone-iodine vaginal cleansing beforehand.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "low-quality evidence",
          "heading": false
        },
        {
          "term": "antibiotic prophylaxis",
          "heading": false
        },
        {
          "term": "routine antibiotic",
          "heading": false
        },
        {
          "term": "conditional recommendation",
          "heading": false
        },
        {
          "term": "antibiotic administration",
          "heading": false
        },
        {
          "term": "strong recommendation",
          "heading": false
        },
        {
          "term": "vaginal cleansing",
          "heading": false
        },
        {
          "term": "moderate-quality evidence",
          "heading": false
        }
      ],
      "extract": "PREVENTION OF MATERNAL PERIPARTUM INFECTIONS NEW ■ ■Routine perineal/pubic shaving prior to giving vaginal birth is not recommended. (Conditional recommendation based on very low-quality evidence). Source ■ ■Digital vaginal examination at intervals of four hours is recommended for routine assessment of active first stage of labour in low-risk women. (Strong recommendation based on very low- quality evidence). Source",
      "extractCut": true
    },
    {
      "id": "sec-012-5-labour-and-child-birth",
      "number": "5",
      "title": "Labour and child birth",
      "level": 1,
      "pageStart": 19,
      "pageEnd": 19,
      "labelStart": "13",
      "labelEnd": "13",
      "words": 0,
      "summary": null,
      "keywords": [],
      "extract": null,
      "extractCut": false
    },
    {
      "id": "sec-013-induction-of-labour",
      "number": null,
      "title": "Induction of labour",
      "level": 2,
      "pageStart": 19,
      "pageEnd": 20,
      "labelStart": "13",
      "labelEnd": "14",
      "words": 420,
      "summary": {
        "text": "Sets out recommendations on when to induce labour, such as at 41 completed weeks or after prelabour membrane rupture at term, but not for uncomplicated pregnancies before 41 weeks, gestational diabetes alone or suspected macrosomia. Recommended methods include oral or low-dose vaginal misoprostol (not after previous caesarean), vaginal prostaglandins, balloon catheter with or without oxytocin and membrane sweeping, with betamimetics for uterine hyperstimulation and outpatient induction not recommended.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "induction",
          "heading": true
        },
        {
          "term": "source induction",
          "heading": false
        },
        {
          "term": "labour",
          "heading": true
        },
        {
          "term": "weak recommendation",
          "heading": false
        },
        {
          "term": "strong recommendation",
          "heading": false
        },
        {
          "term": "vaginal misoprostol",
          "heading": false
        },
        {
          "term": "balloon catheter",
          "heading": false
        },
        {
          "term": "quality evidence",
          "heading": false
        }
      ],
      "extract": "When induction of labour may be appropriate ■ ■Induction of labour is recommended for women who are known with certainty to have reached 41 weeks (>40 weeks + 7 days) of gestation. (Weak recommendation, low quality of evidence). Source ■ ■Induction of labour is not recommended in women with an uncomplicated pregnancy at gestational age less than 41 weeks. (Weak recommendation, low quality of evidence). Source ■ ■If",
      "extractCut": true
    },
    {
      "id": "sec-014-delay-in-the-first-stage-of-labour",
      "number": null,
      "title": "Delay in the first stage of labour",
      "level": 2,
      "pageStart": 20,
      "pageEnd": 21,
      "labelStart": "14",
      "labelEnd": "15",
      "words": 559,
      "summary": {
        "text": "Presents new recommendations on monitoring and managing delay in the first stage of labour, including a partograph with a four-hour action line and four-hourly vaginal examinations, with active management packages, early amniotomy, routine oxytocin, antispasmodics, intravenous fluids and enemas not recommended for prevention. Oral intake, mobility, upright positions and continuous companionship are encouraged, and for confirmed delay oxytocin alone or with amniotomy is recommended, but not oral misoprostol, high-dose regimens or internal tocodynamometry.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "labour",
          "heading": true
        },
        {
          "term": "recommendation weak",
          "heading": false
        },
        {
          "term": "labour augmentation",
          "heading": false
        },
        {
          "term": "delay",
          "heading": true
        },
        {
          "term": "recommendation strong",
          "heading": false
        },
        {
          "term": "amniotomy alone",
          "heading": false
        },
        {
          "term": "during labour",
          "heading": false
        },
        {
          "term": "strength",
          "heading": false
        }
      ],
      "extract": "NEW ■ ■Active phase partograph with a four-hour action line is recommended for monitoring the progress of labour. (Quality of evidence low, Strength of recommendation strong). Source ■ ■Digital vaginal examination at intervals of four hours is recommended for routine assessment and identification of delay in active labour. (Quality of evidence very low, Strength of recommendation weak). Source Prevention of delay in",
      "extractCut": true
    },
    {
      "id": "sec-015-6-prevention-of-postpartum-haemorrhage",
      "number": "6",
      "title": "Prevention of postpartum haemorrhage",
      "level": 1,
      "pageStart": 21,
      "pageEnd": 22,
      "labelStart": "15",
      "labelEnd": "16",
      "words": 366,
      "summary": {
        "text": "Sets out recommendations to prevent postpartum haemorrhage, chiefly a uterotonic for every birth with oxytocin preferred, alternatives such as ergometrine or oral misoprostol where oxytocin is unavailable, and misoprostol given by community and lay health workers where no skilled attendant is present. It also covers controlled cord traction depending on attendant availability, late rather than early cord clamping, no sustained uterine massage after oxytocin, routine uterine tone checks, and oxytocin and cord traction in caesarean section.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "source oxytocin",
          "heading": false
        },
        {
          "term": "strong recommendation",
          "heading": false
        },
        {
          "term": "cord clamping",
          "heading": false
        },
        {
          "term": "recommended uterotonic",
          "heading": false
        },
        {
          "term": "weak recommendation",
          "heading": false
        },
        {
          "term": "moderate quality",
          "heading": false
        },
        {
          "term": "birth attendants",
          "heading": false
        },
        {
          "term": "quality evidence",
          "heading": false
        }
      ],
      "extract": "PREVENTION OF POSTPARTUM HAEMORRHAGE (PPH) ■ ■The use of uterotonics for the prevention of PPH during the third stage of labour is recommended for all births. (Strong recommendation, moderate quality evidence). Source ■ ■Oxytocin (10 IU, IV/IM) is the recommended uterotonic drug for the prevention of PPH. (Strong recommendation, moderate quality evidence). Source ■ ■In settings where oxytocin is unavailable, the use",
      "extractCut": true
    },
    {
      "id": "sec-016-7-postnatal-care",
      "number": "7",
      "title": "Postnatal care",
      "level": 1,
      "pageStart": 22,
      "pageEnd": 25,
      "labelStart": "16",
      "labelEnd": "19",
      "words": 1151,
      "summary": {
        "text": "Sets out WHO recommendations on postnatal care, including a stay of at least 24 hours in the facility after an uncomplicated birth and a schedule of at least four postnatal contacts, with home visits in the first week. It describes how the mother should be assessed in the first day and at later contacts, covering bleeding, vital signs, recovery, breastfeeding, mood, depression and signs of domestic abuse. It also lists counselling topics, warning signs to report, nutrition advice with iron and folic acid supplementation, and psychosocial support, family planning, hygiene and exercise.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "postnatal care",
          "heading": true
        },
        {
          "term": "gdg consensus",
          "heading": false
        },
        {
          "term": "source women",
          "heading": false
        },
        {
          "term": "postpartum women",
          "heading": false
        },
        {
          "term": "postpartum depression",
          "heading": false
        },
        {
          "term": "postnatal contact",
          "heading": false
        },
        {
          "term": "consensus based",
          "heading": false
        },
        {
          "term": "birth spacing",
          "heading": false
        }
      ],
      "extract": "POSTNATAL CARE Timing of discharge from the health facility ■ ■After an uncomplicated vaginal birth in a health facility, healthy mothers and newborns should receive care in the facility for at least 24 hours after birth. (Weak recommendation, low quality evidence). Source Timing and number of postnatal contacts ■ ■If birth is in a health facility, mothers and newborns should receive postnatal care in the facility",
      "extractCut": true
    },
    {
      "id": "sec-017-8-health-promotion-for-maternal-and-newborn-heal",
      "number": "8",
      "title": ". Health promotion for maternal and newborn health",
      "level": 1,
      "pageStart": 25,
      "pageEnd": 28,
      "labelStart": "19",
      "labelEnd": "22",
      "words": 816,
      "summary": {
        "text": "Lists WHO recommendations on health promotion for maternal and newborn health, such as birth preparedness, involving men, maternity waiting homes, community transport schemes, partnership with traditional birth attendants and a companion of choice during labour. It also recommends community engagement through women's groups and community participation in quality improvement and programme planning, and calls for more research on community roles in maternal death surveillance and on rights awareness.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "newborn health",
          "heading": true
        },
        {
          "term": "low-quality evidence",
          "heading": false
        },
        {
          "term": "skilled care",
          "heading": false
        },
        {
          "term": "women voices",
          "heading": false
        },
        {
          "term": "maternity care",
          "heading": false
        },
        {
          "term": "strong recommendation",
          "heading": false
        },
        {
          "term": "quality skilled",
          "heading": false
        },
        {
          "term": "maternity waiting",
          "heading": false
        }
      ],
      "extract": "HEALTH PROMOTION FOR MATERNAL AND NEWBORN HEALTH NEW Birth Preparedness and Complication Readiness ■ ■Birth Preparedness and Complication Readiness interventions are recommended to increase the use of skilled care at birth and to increase the timely use of facility care for obstetric and newborn complications. (Strong recommendation, very low quality of evidence). Additional research is required. Source Male",
      "extractCut": true
    },
    {
      "id": "sec-018-management-of-maternal-conditions",
      "number": null,
      "title": "Management of maternal conditions",
      "level": 1,
      "pageStart": 28,
      "pageEnd": 28,
      "labelStart": "22",
      "labelEnd": "22",
      "words": 2,
      "summary": {
        "text": "A section heading for the management of maternal conditions.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "maternal conditions",
      "extractCut": false
    },
    {
      "id": "sec-019-9-postpartum-haemorrhage",
      "number": "9",
      "title": "Postpartum haemorrhage",
      "level": 1,
      "pageStart": 28,
      "pageEnd": 29,
      "labelStart": "22",
      "labelEnd": "23",
      "words": 692,
      "summary": {
        "text": "Sets out WHO recommendations for treating postpartum haemorrhage, starting with intravenous oxytocin and alternative uterotonics, crystalloid fluids, tranexamic acid and uterine massage. It then covers escalating and temporizing measures such as balloon tamponade, embolization, surgery, bimanual or aortic compression and anti-shock garments, along with the management of retained placenta. The block ends with the first recommendations on pre-eclampsia and eclampsia, favouring magnesium sulfate over other anticonvulsants.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "uterine atony",
          "heading": false
        },
        {
          "term": "weak recommendation",
          "heading": false
        },
        {
          "term": "magnesium sulfate",
          "heading": false
        },
        {
          "term": "uterine massage",
          "heading": false
        },
        {
          "term": "source magnesium",
          "heading": false
        },
        {
          "term": "intravenous oxytocin",
          "heading": false
        },
        {
          "term": "pph due",
          "heading": false
        },
        {
          "term": "strong recommendation",
          "heading": false
        }
      ],
      "extract": "TREATMENT OF POSTPARTUM HAEMORRHAGE3 ■ ■Intravenous oxytocin alone is the recommended uterotonic drug for the treatment of PPH. (Strong recommendation, moderate quality evidence). Source ■ ■If intravenous oxytocin is unavailable, or if the bleeding does not respond to oxytocin, the use of intravenous ergometrine, oxytocin-ergometrine fixed dose, or a prostaglandin drug (including sublingual misoprostol, 800 µg) is",
      "extractCut": true
    },
    {
      "id": "sec-020-10-pre-eclampsia-and-eclampsia",
      "number": "10",
      "title": "Pre-eclampsia and eclampsia",
      "level": 1,
      "pageStart": 29,
      "pageEnd": 30,
      "labelStart": "23",
      "labelEnd": "24",
      "words": 256,
      "summary": {
        "text": "Continues WHO recommendations on severe pre-eclampsia, covering when to induce labour, when expectant management is acceptable by gestational age, and early delivery at term. It also recommends continuing or starting antihypertensive treatment after birth and advises against corticosteroids specifically for HELLP syndrome.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "weak recommendation",
          "heading": false
        },
        {
          "term": "pre-eclampsia",
          "heading": true
        },
        {
          "term": "severe pre-eclampsia",
          "heading": false
        },
        {
          "term": "maternal hypertension",
          "heading": false
        },
        {
          "term": "viable fetus",
          "heading": false
        },
        {
          "term": "strong recommendation",
          "heading": false
        },
        {
          "term": "antihypertensive drugs",
          "heading": false
        },
        {
          "term": "uncontrolled maternal",
          "heading": false
        }
      ],
      "extract": "(Weak recommendation, very low quality evidence). Source ■ ■Induction of labour is recommended for women with severe preeclampsia at a gestational age when the fetus is not viable or unlikely to achieve viability within one or two weeks. (Strong recommendation, very low quality evidence). Source ■ ■In women with severe pre-eclampsia, a viable fetus and before 34 weeks of gestation, a policy of expectant management",
      "extractCut": true
    },
    {
      "id": "sec-021-11-peripartum-infections",
      "number": "11",
      "title": "Peripartum infections",
      "level": 1,
      "pageStart": 30,
      "pageEnd": 30,
      "labelStart": "24",
      "labelEnd": "24",
      "words": 57,
      "summary": {
        "text": "Recommends first-line antibiotic regimens for chorioamnionitis (ampicillin with once-daily gentamicin) and for postpartum endometritis (clindamycin with gentamicin).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "conditional recommendation",
          "heading": false
        },
        {
          "term": "recommendation based",
          "heading": false
        },
        {
          "term": "antibiotics",
          "heading": false
        }
      ],
      "extract": "NEW ■ ■A simple regimen such as ampicillin and once-daily gentamicin is recommended as first- line antibiotics for the treatment of chorioamnionitis. (Conditional recommendation based on very low-quality evidence). Source ■ ■A combination of clindamycin and gentamicin is recommended as first-line antibiotics for the treatment of postpartum endometritis. (Conditional recommendation based on very low- quality",
      "extractCut": true
    },
    {
      "id": "sec-022-12-hiv-infection",
      "number": "12",
      "title": "HIV infection",
      "level": 1,
      "pageStart": 30,
      "pageEnd": 33,
      "labelStart": "24",
      "labelEnd": "27",
      "words": 1052,
      "summary": {
        "text": "Sets out WHO recommendations on HIV in pregnant and breastfeeding women, starting with couple testing and provider-initiated testing in generalized and low-level epidemics. It covers when to start antiretroviral therapy, practices to reduce transmission during labour and delivery, non-stigmatizing care, and follow-up of mothers and HIV-exposed infants. It also names the preferred first-line ART regimen, infant prophylaxis by feeding type, and advises against vitamin A supplementation to reduce mother-to-child transmission.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "hiv infection",
          "heading": true
        },
        {
          "term": "source quoted",
          "heading": false
        },
        {
          "term": "breastfeeding women",
          "heading": false
        },
        {
          "term": "pregnant women",
          "heading": false
        },
        {
          "term": "lifelong art",
          "heading": false
        },
        {
          "term": "strong recommendation",
          "heading": false
        },
        {
          "term": "quality evidence",
          "heading": false
        },
        {
          "term": "epidemics provider-initiated",
          "heading": false
        }
      ],
      "extract": "HIV diagnosis ■ ■Couples and partners in antenatal care settings should be offered voluntary HIV testing and counselling with support for mutual disclosure. (Strong recommendation, low quality evidence). Source Generalized epidemics ■ ■Provider-initiated testing and counselling is recommended for women as a routine component of the package of care in all antenatal, childbirth, postpartum and paediatric care",
      "extractCut": true
    },
    {
      "id": "sec-023-13-malaria",
      "number": "13",
      "title": "Malaria",
      "level": 1,
      "pageStart": 33,
      "pageEnd": 33,
      "labelStart": "27",
      "labelEnd": "27",
      "words": 79,
      "summary": {
        "text": "Gives WHO recommendations for uncomplicated falciparum malaria in the first trimester (seven days of quinine plus clindamycin) and for chloroquine chemoprophylaxis in pregnant or breastfeeding women, followed by primaquine depending on G6PD status.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "falciparum malaria",
          "heading": false
        },
        {
          "term": "uncomplicated",
          "heading": false
        },
        {
          "term": "trimester",
          "heading": false
        }
      ],
      "extract": "NEW Treating uncomplicated P. falciparum malaria in special risk groups First trimester of pregnancy ■ ■Treat pregnant women with uncomplicated P. falciparum malaria during the first trimester with 7 days of quinine + clindamycin. (Strong recommendation). Source Pregnant and breastfeeding women ■ ■In women who are pregnant or breastfeeding, consider weekly chemoprophylaxis with chloroquine until delivery and",
      "extractCut": true
    },
    {
      "id": "sec-024-14-tuberculosis",
      "number": "14",
      "title": "Tuberculosis",
      "level": 1,
      "pageStart": 33,
      "pageEnd": 36,
      "labelStart": "27",
      "labelEnd": "30",
      "words": 285,
      "summary": {
        "text": "Sets out WHO recommendations on nutritional care for pregnant and lactating women with active tuberculosis, including fortified or supplementary foods to reach a target weekly weight gain. It also recommends multiple micronutrient supplements with iron and folic acid, and calcium to prevent pre-eclampsia where intake is low.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "multiple micronutrient",
          "heading": false
        },
        {
          "term": "maternal micronutrient",
          "heading": false
        },
        {
          "term": "fortified supplementary",
          "heading": false
        },
        {
          "term": "micronutrient preparation",
          "heading": false
        },
        {
          "term": "supplementary foods",
          "heading": false
        },
        {
          "term": "moderate undernutrition",
          "heading": false
        },
        {
          "term": "conditional recommendation",
          "heading": false
        },
        {
          "term": "strong recommendation",
          "heading": false
        }
      ],
      "extract": "NEW Nutritional Care and support for patients with tuberculosis ■ ■Pregnant women with active TB and moderate undernutrition, or with inadequate weight gain, should be provided with locally available nutrient rich or fortified supplementary foods, as necessary to achieve an average weekly minimum weight gain of approximately 300 g in the second and third trimesters. (Strong recommendation, very low quality of",
      "extractCut": true
    }
  ],
  "checks": {
    "tocAlignment": {
      "listed_not_found": {
        "count": 6,
        "items": [
          "Nutritional supplements",
          "Delay in the first stage of labour",
          "Augmentation of labour",
          "Pre-eclampsia and eclampsia",
          "Peripartum infections",
          "Malaria"
        ]
      },
      "found_not_listed": {
        "count": 5,
        "items": [
          "1 ANTENATAL CARE FOR A POSITIVE PREGNANCY EXPERIENCE",
          "10 INTERVENTIONS FOR TREATMENT OF PRE-ECLAMPSIA AND ECLAMPSIA",
          "12 HIV INFECTION DURING PREGNANCY",
          "13 MALARIA DURING PREGNANCY",
          "14 TUBERCULOSIS DURING PREGNANCY"
        ]
      },
      "page_mismatch": {
        "count": 1,
        "items": [
          "Postpartum haemorrhage: listed p28, found p6"
        ]
      }
    },
    "figureSequenceGaps": [],
    "pageLabelConflicts": {
      "count": 0,
      "items": []
    }
  },
  "withheld": false,
  "keywords": [
    {
      "term": "source women",
      "heading": false
    },
    {
      "term": "recommendation strong",
      "heading": false
    },
    {
      "term": "recommendation weak",
      "heading": false
    },
    {
      "term": "conditional recommendation",
      "heading": false
    },
    {
      "term": "source antenatal",
      "heading": false
    },
    {
      "term": "context-specific recommendation",
      "heading": false
    },
    {
      "term": "source oxytocin",
      "heading": false
    },
    {
      "term": "source health",
      "heading": false
    },
    {
      "term": "recommendation based",
      "heading": false
    },
    {
      "term": "source antibiotic",
      "heading": false
    },
    {
      "term": "source induction",
      "heading": false
    },
    {
      "term": "recommendation research",
      "heading": false
    }
  ],
  "pageLabels": [
    {
      "physical": 1,
      "label": "A",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 2,
      "label": "B",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 3,
      "label": "i",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 4,
      "label": "ii",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 5,
      "label": "iii",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 6,
      "label": "iv",
      "source": "pdf-labels",
      "confidence": 0.85
    },
    {
      "physical": 7,
      "label": "1",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 8,
      "label": "2",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 9,
      "label": "3",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 10,
      "label": "4",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 11,
      "label": "5",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 12,
      "label": "6",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 13,
      "label": "7",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 14,
      "label": "8",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 15,
      "label": "9",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 16,
      "label": "10",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 17,
      "label": "11",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 18,
      "label": "12",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 19,
      "label": "13",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 20,
      "label": "14",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 21,
      "label": "15",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 22,
      "label": "16",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 23,
      "label": "17",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 24,
      "label": "18",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 25,
      "label": "19",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 26,
      "label": "20",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 27,
      "label": "21",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 28,
      "label": "22",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 29,
      "label": "23",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 30,
      "label": "24",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 31,
      "label": "25",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 32,
      "label": "26",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 33,
      "label": "27",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 34,
      "label": "28",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 35,
      "label": "29",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 36,
      "label": "30",
      "source": "pdf-labels",
      "confidence": 0.7
    }
  ],
  "figures": [],
  "coverage": [
    {
      "kind": "contents",
      "state": "found",
      "count": 26,
      "note": "inferred"
    },
    {
      "kind": "sections",
      "state": "found",
      "count": 26,
      "note": "2 levels"
    },
    {
      "kind": "figures",
      "state": "none"
    },
    {
      "kind": "tables",
      "state": "not-extracted"
    },
    {
      "kind": "references",
      "state": "none",
      "note": "no such heading in the text"
    },
    {
      "kind": "glossary",
      "state": "not-extracted",
      "note": "a glossary section is in the text (p6); its entries are not extracted"
    },
    {
      "kind": "footnotes",
      "state": "found",
      "count": 3
    },
    {
      "kind": "summaries",
      "state": "partial",
      "count": 25,
      "note": "25 of 26 sections"
    }
  ],
  "links": {
    "repo": "litlfred/who-iris",
    "branch": "main",
    "dir": "library/10665-259268"
  }
}
